Subtype
Glioma
CI-CAN-00000935Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000935Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02864888 | Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma(DBSG) | not yet recruiting | Phase 3 | 30 | Burzynski Research InstituteOTHER | 0 | Sep 19, 2025 | clinicaltrials |
| NCT02887040 | Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma(DIPG) | not yet recruiting | Phase 3 | 92 | Burzynski Research InstituteOTHER | 0 |
| Sep 16, 2025 |
| clinicaltrials |
| NCT07021573 | Protoporphyrin Imaging in Multispectral Evaluation of Resections(PRIMER) | not yet recruiting | N/A | 80 | Medical University InnsbruckOTHER | 3 | Sep 9, 2025 | clinicaltrials |
| NCT07162324 | A Multicenter, Prospective Study for Glioblastoma Patients | not yet recruiting | — | 100 | Larissa University HospitalOTHER | 3 | Sep 9, 2025 | clinicaltrials |
| NCT07138001 | Phase 2 Clinical Trial of KH617 | not yet recruiting | Phase 2 | 60 | Sichuan Honghe Biotechnology Co., Ltd.INDUSTRY | 0 | Aug 22, 2025 | clinicaltrials |
| NCT07120984 | A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma(IMAGLIO) | not yet recruiting | Phase 2 | 52 | Philogen S.p.A.INDUSTRY | 0 | Aug 13, 2025 | clinicaltrials |
| NCT06617208 | Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery(PIONEER) | not yet recruiting | N/A | 10 | Erasmus Medical CenterOTHER | 0 | Aug 8, 2025 | clinicaltrials |
| NCT07106008 | Radiolabeled TSPO Targeted Molecular Probe in Glioma | not yet recruiting | — | 8 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 0 | Aug 6, 2025 | clinicaltrials |
| NCT07047066 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma | not yet recruiting | Phase 2 | 30 | Tongji HospitalOTHER | 0 | Jul 2, 2025 | clinicaltrials |
| NCT07029100 | Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.(ORGA-GLIO) | not yet recruiting | N/A | 30 | Centre Henri BecquerelOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT07004075 | FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration | not yet recruiting | Phase 3 | 102 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Jun 4, 2025 | clinicaltrials |
| NCT01777919 | Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform(GLIODIS) | not yet recruiting | Phase 2 | 32 | Olympion Medical CenterOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06869577 | A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma(SUGRI) | not yet recruiting | N/A | 24 | Rigshospitalet, DenmarkOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06750458 | Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients | not yet recruiting | Phase 3 | 75 | Tanta UniversityOTHER | 0 | Apr 22, 2025 | clinicaltrials |
| NCT06939400 | Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence | not yet recruiting | — | 100 | Zhejiang Provincial People's HospitalOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06929819 | Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor | not yet recruiting | N/A | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT06914427 | PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique | not yet recruiting | N/A | 35 | Xijing HospitalOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06749925 | Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma | not yet recruiting | Phase 3 | 186 | University of Sao Paulo General HospitalOTHER | 0 | Apr 1, 2025 | clinicaltrials |
| NCT06323408 | Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas(BZKF-AYA) | not yet recruiting | — | 72 | University Hospital RegensburgOTHER | 0 | Mar 25, 2025 | clinicaltrials |
| NCT06781372 | Patient's Derived Organoids for Drug Screening in Glioblastoma(GlioPDO) | not yet recruiting | N/A | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06408428 | Glioma Intraoperative MicroElectroCorticoGraphy(MicroECoGG) | not yet recruiting | N/A | 50 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06845020 | CSF Proteomic Characterization of Glioblastomas | not yet recruiting | — | 15 | Univeridad Autonoma de GuadalajaraOTHER | 0 | Feb 25, 2025 | clinicaltrials |
| NCT06780592 | Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery | not yet recruiting | Phase 2 | 60 | Huashan HospitalOTHER | 0 | Jan 22, 2025 | clinicaltrials |
| NCT06764537 | Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma(BOOSTCAR) | not yet recruiting | N/A | 18 | Central Hospital, Nancy, FranceOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06737146 | Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma | not yet recruiting | Phase 1 | 12 | Suzhou Maximum Bio-tech Co., Ltd.INDUSTRY | 1 | Dec 17, 2024 | clinicaltrials |
| NCT06684899 | Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients(KillGlio) | not yet recruiting | — | 40 | IRCCS San RaffaeleOTHER | 0 | Nov 14, 2024 | clinicaltrials |
| NCT06657027 | Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma(ARTPLAN-GLIO) | not yet recruiting | — | 40 | Hospital del Rio HortegaOTHER | 0 | Oct 24, 2024 | clinicaltrials |
| NCT06258018 | Niraparib and Temozolomide in Patients Glioblastoma(ONC-2022-001) | not yet recruiting | Phase 1 / Phase 2 | 86 | Armando Santoro, MDOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06572592 | The Predictive Value of MRI for Adult-type Diffuse Gliomas(MRI; glioma;) | not yet recruiting | — | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Aug 27, 2024 | clinicaltrials |
| NCT04933422 | CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) | not yet recruiting | Phase 1 | 72 | Crimson Biopharm Inc.INDUSTRY | 0 | Aug 21, 2024 | clinicaltrials |
| NCT06524063 | Targeted Survivin DC Cell Injection for the Treatment of GBM | not yet recruiting | Phase 1 | 9 | Beijing Tricision Biotherapeutics IncINDUSTRY | 0 | Jul 29, 2024 | clinicaltrials |
| NCT06512298 | Plasticizer Exposure and Its Consequences on Health(PEACH) | not yet recruiting | — | 120 | Medical University of ViennaOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06499636 | In Vitro Models From Pediatric Brain Tumors(PBTS23) | not yet recruiting | — | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT06485908 | Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma(MEPENDAX) | not yet recruiting | Phase 1 / Phase 2 | 40 | Assistance Publique Hopitaux De MarseilleOTHER | 0 | Jul 3, 2024 | clinicaltrials |
| NCT06480721 | FET-PET-Guided Management of Pseudoprogression in Glioblastoma(FET-POPPING) | not yet recruiting | N/A | 144 | Veerle RuijtersOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06477939 | Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients(THREE-GLEES) | not yet recruiting | Phase 3 | 554 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT06396481 | Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma(CSAγδTBMG) | not yet recruiting | Early Phase 1 | 25 | Beijing Tiantan HospitalOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06368934 | Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma | not yet recruiting | N/A | 326 | Huashan HospitalOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03763396 | Azoles Targeting Recurrent High Grade Gliomas | not yet recruiting | Early Phase 1 | 30 | University Health Network, TorontoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06218524 | The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM | not yet recruiting | Phase 2 | 200 | Southern Medical University, ChinaOTHER | 0 | Jan 23, 2024 | clinicaltrials |
| NCT06201351 | Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI | not yet recruiting | — | 60 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06093165 | RE-irradiation of Diffuse MIdline Glioma paTients(REMIT) | not yet recruiting | N/A | 59 | Rigshospitalet, DenmarkOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT05540275 | Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma | not yet recruiting | Phase 2 | 30 | Henan Provincial People's HospitalOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06017063 | Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields(COCOON) | not yet recruiting | N/A | 275 | University Hospital TuebingenOTHER | 0 | Aug 30, 2023 | clinicaltrials |
| NCT05917821 | New Antigens Against Glioblastoma(INAAG) | not yet recruiting | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jul 24, 2023 | clinicaltrials |
| NCT05842746 | Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma | not yet recruiting | Phase 2 | 74 | Peking Union Medical College HospitalOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05100641 | AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM | not yet recruiting | Phase 3 | 672 | Aivita Biomedical, Inc.INDUSTRY | 0 | Apr 10, 2023 | clinicaltrials |
| NCT05641220 | Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.(BIOPSY) | not yet recruiting | — | 325 | Erasmus Medical CenterOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05502991 | Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma | not yet recruiting | Phase 2 | 60 | Henan Provincial People's HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT05532969 | Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma | not yet recruiting | — | 60 | Henan Provincial People's HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Sep 19, 2025source: clinicaltrials